Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

OCUL is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of OCUL shares has increased $0.96 since the market last closed. This is a 10.84% ...

#brittonhardin #overtime #otx britton hardin of overtime BOXING- expanding into other markets | open scoring fights | tournament #Boxing American teacher posts foul photos comparing school lunch in ...

Bristol Myers Squibb has ended the week with an agreement to buy Orbital Therapeutics – a developer of in vivo cell therapies – for $1.5 billion in cash. Cambridge, Massachusetts-based Orbital is ...

Sanofi is reported to be preparing a move to take control of US biotech Ocular Therapeutix, after an initial bid was rejected last year. That is according to French newspaper La Lettre, which said ...

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes ...

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes ...

Mondas are a cyber security consultancy leveraging the speed and scale of automation technologies to enhance your security capabilities. We help both in-house security teams and MSSPs to rapidly adopt ...

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.